Back
Monopar Therapeutics Stock Price Chart
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
45
MNPR
Monopar Therapeutics
Last Price:
$37.00
Seasonality Move:
-0.36%
7 Day Trial
ALL ACCESS PASS
$
7
Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Monopar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.54 | Buy |
| 20-day SMA: | 35.88 | Sell |
| 50-day SMA: | 37.45 | Sell |
| 200-day SMA: | 18.77 | Buy |
| 8-day EMA: | 33.07 | Buy |
| 20-day EMA: | 34.25 | Buy |
| 50-day EMA: | 34.31 | Buy |
| 200-day EMA: | 22.99 | Buy |
Monopar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.96 | Sell |
| Relative Strength Index (14 RSI): | 50.48 | Buy |
| Chaikin Money Flow: | 13636 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.06 - 39.14) | Buy |
| Bollinger Bands (100): | (22.84 - 40.4) | Buy |
Monopar Therapeutics Technical Analysis
| Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 34.89 while MNPR 8-day simple moving average is 32.54, which is a Buy signal.
-
The stock price of MNPR is 34.89 while Monopar Therapeutics 20-day SMA is 35.88, which makes it a Sell.
-
Monopar Therapeutics 50-day simple moving average is 37.45 while MNPR share price is 34.89, making it a Sell technically.
-
MNPR stock price is 34.89 and Monopar Therapeutics 200-day simple moving average is 18.77, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Sell
45
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a SellThe current Monopar Therapeutics [MNPR] share price is $34.89. The Score for MNPR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
213.3M
Price in USD:
34.89
Share Volume:
14.8K
Monopar Therapeutics 52-Week Range
52-Week High:
54.30
52-Week Low:
1.72
Sell
45
Monopar Therapeutics (MNPR)
is a Sell
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?The Monopar Therapeutics stock price is 34.89 USD today.
-
Will MNPR stock go up or go down?Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Monopar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is overvalued.
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 34.89 while MNPR 8-day exponential moving average is 33.07, which is a Buy signal.
-
The stock price of MNPR is 34.89 while Monopar Therapeutics 20-day EMA is 34.25, which makes it a Buy.
-
Monopar Therapeutics 50-day exponential moving average is 34.31 while MNPR share price is 34.89, making it a Buy technically.
-
MNPR stock price is 34.89 and Monopar Therapeutics 200-day simple moving average is 22.99, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.46 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.86 per share, and an increase next year of $0.69 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
-
MNPR Moving Average Covergence Divergence (MACD) indicator is -0.96, suggesting Monopar Therapeutics is a Sell
-
Monopar Therapeutics Relative Strength Index (RSI) is 50.48, which suggest Monopar Therapeutics is overbought
-
The Bollinger Bands (25) for Monopar Therapeutics is (30.06 - 39.14), which suggest Monopar Therapeutics is a Buy
-
The Bollinger Bands (100) for Monopar Therapeutics is (22.84 - 40.4), which suggest Monopar Therapeutics is a Buy
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.